IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

International Biotechnology Trust PLC

Q1 2023 Holdings

Filed 2023-05-18 | 64 holdings | $358.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$9.1M244,0002.5%
Regeneron Pharms.(REGN)COM75886F107$9.2M11,2002.6%
Alnylam Pharms.(ALNY)COM02043Q107$9.3M46,6002.6%
Uniqure NV(QURE)SHSN90064101$9.6M478,5002.7%
Vertex Pharmaceuticals Inc(VRTX)COM92532F100$10.4M33,0002.9%
Exelixis Inc(EXEL)COM30161Q104$10.5M543,0002.9%
Ultragenyx Pharm.(RARE)COM90400D108$10.6M264,0523.0%
Intra-Cellular Therapies(ITCIEUR)COM46116X101$14.0M257,8563.9%
Supernus Pharms.(SUPN)COM868459108$15.3M423,5004.3%
Alkermes PLC(ALKS)SHSG01767105$16.7M593,0004.7%
Harmony Biosciences Hldgs(HRMY)COM413197104$18.6M570,5005.2%
Incyte Corp(INCY)COM45337C102$20.2M279,0005.6%
Amgen Inc COM(AMGN)COM031162100$22.1M91,2466.2%
Seagen Inc(SGENUSD)COM81181C104$40.5M200,20011.3%
PreviousPage 2 of 2